« Back to the previous page

Also available in:

Medical supplements manufacturer Europe for a sale

Company for sale

  • Size: medium sized
  • Revenue: > EUR 10m (growing 20% plus a year)
  • EBITDA: 30% of revenue with a possibility to increase once the business grows further
  • Valuation demands: > Euro 15m
  • Employees: > 15
  • Location of the medical supplements manufacturer: Eastern Europe
  • Reason for sale: The company grows very fast and the owner wants to expand in other countries and grow it’s product portfolio which is best done in combination with a strong strategic buyer
  • #CFIE PHS039

Overview of the medical supplements manufacturer Europe open for a sale

This firm provides a range of activities of which the most important one is the manufacturing of own medical devices and supplements. This is an area with high margins and further opportunity for growth. The company for sale also represents various large biotech companies in it’s home country and has the capacity to grow to further neighbouring countries. The company has grown very fast over the last years and has further potential to grow. The owner wants to install a further management team and his personal choices will want him to move to a more strategic position in the company. Given the company has large further potential to grow additional investments of a strong partner (preferably strategic) are welcome. The owner wants to retain a minority ownership and stay actively involved in the company.

Profile (strategy) for the medical supplements manufacturer Europe open for a sale

The company is active in the field of manufacturing medical supplements. Some of the products the company for sale manufacturers are fertility and pregnancy tests. The company is strong in this field and can extend the range of consumer tests to drug abuse and other new ones. Further products the company manufacturers are medical dietary supplements. The company represents many high quality international biotech companies in it’s home country. The strategy is to start representing the same biotech companies in other neighbouring countries as well. Given there is large opportunity the owner prefers to do this in combination with a larger, preferably strategic, investor. A financial investor is also possible as the margins and growth opportunity of the company are very good.

Buy this medical
supplements manufacturer

Contact us to get details about this medical supplements manufacturer Europe for a sale

Activities, products and services of the medical supplements manufacturer in Europe open for a sale

The company is focused in providing solutions to a large group of clients:
  • Product manufacturing (it is growing an own product portfolio with products ranging from of consumer tests for fertility and pregnancy tests, drug abuse to medical dietary supplements)
  • The company for sale is representing large biotech companies in it’s home market
  • Clinical trials (the company also has the ability to provide clinical trials)
The company has state-of-the-art facilities and well-trained employees who have deep expertise in their respective fields. The team is capable to grow the business further with successful new products.

Highlights for the medical supplements manufacturer in Europe open for a sale

  • The organization has leading expertise and successful products
  • The company is very profitable and has interesting margins
  • The company has a well-diversified client base
  • The firm has scalable operations especially in the field of developing it’s own products
  • The company is owned by a private individual who would like to team up with a larger strategic (or financial) buyer

Information for the medical supplements manufacturer Europe open for a sale

Feel free to contact us for more information regarding this medical supplements manufacturing organisation for sale in Europe. If this manufacturing organisation for sale based in Europe does not fit your requirements feel free to ask for other pharma companies for sale. For other pharma buyers please visit the page pharma companies wanted.